Harrisvaccines awarded avian influenza contract
According to a statement released by the company, this contract will last for two years; they will be providing 48 million doses of avian influenza H5, which will be used in order to develop the National Veterinary Stockpile of the USDA’s Animal and Plant Health Inspection Service (APHIS).
“The Harrisvaccines team is honored to assist the USDA in the continued fight against avian influenza,” Hank Harris, founder and CEO of Harrisvaccines, said. “By stockpiling our pioneering RNA particle vaccine, the U.S. is taking an important first step in protecting our poultry and egg producers against another overwhelming loss. Harrisvaccines is proud to be a part of that effort.”
The company states that it will be able to provide approximately 25 million of the needed doses within a 45-day time frame. The virus is highly contagious. It affects many poultry species and can be spread to humans. The company reports that in Iowa, 31 million birds have died from the illness to date.
At this time, the announcement states that this is not an order for mass vaccination for highly pathogenic avian influenza.